Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Ordinary Shares, par value 0.05 euro per share
-
Shares outstanding
-
61.5M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
40M
-
Shares change
-
-1.83M
-
Total reported value, excl. options
-
$907M
-
Value change
-
-$33.4M
-
Put/Call ratio
-
0.23
-
Number of buys
-
89
-
Number of sells
-
-78
-
Price
-
$22.67
Significant Holders of uniQure N.V. - Ordinary Shares, par value 0.05 euro per share (QURE) as of Q4 2022
214 filings reported holding QURE - uniQure N.V. - Ordinary Shares, par value 0.05 euro per share as of Q4 2022.
uniQure N.V. - Ordinary Shares, par value 0.05 euro per share (QURE) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40M shares
of 61.5M outstanding shares and own 65.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.98M shares), STATE STREET CORP (2.72M shares), FMR LLC (2.7M shares), Nantahala Capital Management, LLC (2.7M shares), PFM Health Sciences, LP (2.3M shares), ORBIMED ADVISORS LLC (1.75M shares), Point72 Asset Management, L.P. (1.67M shares), VANGUARD GROUP INC (1.41M shares), 683 Capital Management, LLC (1.15M shares), and MORGAN STANLEY (1.06M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.